MedPath

Evaluation of Visual - Motor Development in Children With Retinopathy of Prematurity

Completed
Conditions
Visual Impairment
Premature Retinopathy
Motor Delay
Registration Number
NCT03865134
Lead Sponsor
Istanbul Medipol University Hospital
Brief Summary

The aim of this study was to investigate the eye structure, visual impairment, visual motor development and motor coordination of children between 2-6 ages that had applied to diod laser photocoagulation and intravitreal anti - vascular endothelial growth factor treatment.

Detailed Description

There are three different groups in this study. Children between 2-6 ages that had applied to diod laser photocoagulation and intravitreal anti - vascular endothelial growth factor treatment will have evaluated with Snellen Test, Titmus Fly Test, Optical Kohlerans Tomography, Beery-Buktenica Developmental Test of Visual Motor Integration, Peabody Developmental Motor Scales-II, World Health Organization Quality of Life - BREF and State - Trait Anxiety Inventory.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
69
Inclusion Criteria
  • Age range between 2-6 years of age
  • Gestational age range 26-34. be between weeks
  • To be diagnosed with retinopathy of prematurity
  • Neurological, hereditary and not having metabolic disease
  • Compliance with visual examinations and physiotherapy evaluations
  • To be children and parents who agree to participate in the study
Exclusion Criteria
  • To be a child who does not comply with Optical Kohlerans Tomography (OCT)
  • Not participating in one or more of the eye examination or physiotherapy assessments
  • Being children and parents who do not agree to participate in the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visual Motor Integration3 weeks

Visual-motor integration (VMI) is "the degree to which visual perception and finger-hand movements are well coordinated" and will asses with Beery-Buktenica Developmental Test of Visual-Motor Integration in this study. This test is a standardized, norm-referenced assessment involving copying geometric forms that is used to determine the level of integration between visual and motor systems in people of all ages.

The Short Format and Full Format tests take about 10-15 minutes each to administer. Results are reported as standard scores, percentiles, and age equivalents.

Visual Perception3 weeks

Visual perception will asses with Beery-Buktenica Developmental Test of Visual-Motor Integration in this study. This test is a standardized, norm-referenced assessment involving copying geometric forms that is used to determine the level of integration between visual and motor systems in people of all ages. Visual Perception test takes about 5 minutes. Results are reported as standard scores, percentiles, and age equivalents.

Motor Coordination3 weeks

Motor Coordination is coordination of finger movements and will asses by Beery-Buktenica Developmental Test of Visual-Motor Integration in this study. This test is a standardized, norm-referenced assessment involving copying geometric forms that is used to determine the level of integration between visual and motor systems in people of all ages. Motor coordination test takes about 5 minutes. Results are reported as standard scores, percentiles, and age equivalents.

Retinal Layers' Development3 weeks

Development of retinal layers will assess with Optical coherence tomography (OCT). The OCT allows for in vivo, cross-sectional assessment of eye tissue, including the retina and its vasculature. By comparing the interference patterns of light that passes through live tissue to a reference arm, OCT provides high-resolution imaging of just a few microns of eye microanatomy.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Istanbul Medipol University

🇹🇷

Istanbul, Beykoz, Turkey

Istanbul Medipol University
🇹🇷Istanbul, Beykoz, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.